Skip to content

Assessment of Time in Range by Daily Blood Glucose Monitor and Continuous Glucose Monitoring

Assessment of Time in Range by Daily Blood Glucose Monitor and Continuous Glucose Monitoring - TIR study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045896
Enrollment
80
Registered
2021-10-28
Start date
2020-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes, Type 2 diabetees

Interventions

None listed

Sponsors

Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 1 diabetes mellitus Type 2 diabetes mellitus Receiving insulin therapy and/or GLP-1RA SMBG more than 20 times per month

Exclusion criteria

Exclusion criteria: Woman of pregnant or planning to get pregnant Blinded patient There are shunts on both left and right arms Using an implantable medical device such as a pacemaker

Design outcomes

Primary

MeasureTime frame
Comparison of TIR obtained from SMBG and CGM.

Secondary

MeasureTime frame
Comparison of TAR and TBR obtained from SMBG and CGM, and correlation with HbA1c and GA.

Countries

Japan

Contacts

Public ContactKanori Iwamatsu

Department of Internal Medicine, Tokai University School of Medicine Division of Nephrology, Endocrinology and Metabolism

k-iwamtsu@tsc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026